LivaNova is a global medical technology company built on nearly five decades of experience and a relentless commitment to improve the lives of patients around the world. Our advanced technologies and breakthrough treatments provide meaningful solutions for the benefit of patients, healthcare professionals and healthcare systems.
At LivaNova, we understand the importance of bringing both clinical and economic value to our customers. We are a strong, market-leading medical technology and services company, offering a diverse product portfolio and global reach. LivaNova is listed on the NASDAQ stock exchange under the ticker symbol “LIVN.”
We are headquartered in London (UK) and maintain a presence in more than 100 countries. LivaNova operates as three business franchises:
• Cardiac Surgeries
• Cardiac Rhythm Management
Medtronic began its operations in India in the year 1979. With over 1100 employees, India Medtronic Pvt. Ltd. is a wholly-owned subsidiary of Medtronic Plc. It is headquartered at Solitaire Corporate Park in Mumbai and has its oﬃces at Ahmedabad, Bangalore, Chennai, Cochin, Dhaka, Gurgaon, Hyderabad, Kolkata, New Delhi, Pune and Vadodara and Colombo.
Our businesses primarily fall into four groups: the Cardiac and Vascular Group (CVG), the Restorative Therapies Group (RTG), the Diabetes Group and the Minimally Invasive Therapies Group (MITG). The Cardiac and Vascular Group encompasses Cardiac Rhythm and Heart Failure (CRHF), Coronary, Structural Heart and Arterial and Peripheral Vascular businesses; the Restorative Therapies Group includes Spine and Biologics, Surgical Technologies, Neuromodulation and Neurovascular businesses; the Diabetes Group oﬀers Insulin Pump Therapy and Continuous Glucose Monitoring Systems (CGMS) and the Minimally Invasive Therapies group comprises of Early Technologies, Advanced Surgical Technologies and General Surgical Products, and Medical Supplies, Respiratory and Monitoring Solutions, and Venous Solutions.
India Medtronic has two Research and Development (R&D) centers, in Bangalore and Hyderabad respectively. The Medtronic India Development Centre (MIDC) – the R&D facility at Bangalore develops the key aspects of Medtronic’s renal care solutions business and the Medtronic Engineering and Innovation Center (MEIC) at Hyderabad provides high quality, cost eﬀective engineering services to Medtronic’s Minimally Invasive Therapies Group (MITG) businesses’ global and regional business units.
Mölnlycke Health Care is a world-leading medical products and solutions company that equips healthcare professionals to achieve the best patient, clinical and economic outcomes. We design and supply products and solutions for use in wound treatment, pressure ulcer, infection prevention and surgery. Our products and solutions provide value for money supported by clinical and health economic evidence.
Olympus Medical Systems India Private Limited commenced its Direct business operation in India from April 1, 2010 with an initial objective to become the most respected, reliable and chosen Brand in healthcare domain in India. Olympus Medical Systems India is a wholly owned subsidiary of Olympus Corporation of Asia Pacific Ltd and have major manufacturing foot prints at Japan and Germany. Through a focussed approach in the market, Olympus has been able to develop a great relationship and visible presence across full spectrum of customer base includes prime education institutes and corporate hospitals in India.
Olympus has a wide portfolio of products that are equipped with the latest innovative and superior technology. Olympus deals primarily in two verticals i.e. Gastrointestinal/ Respiration & Surgical divisions and contribute to the medical society with state of the art product categories that includes, Video Endoscopy, Endoscopic Ultrasound, Bronchoscopy, Endotherapy devices in Gastrointestinal & Respiratory range whereas Surgical division includes High definition imaging system includes 3D & 4K system with high end Energy products to deal with Laproscopy, Genaral surgery, Gynecology and urology field.
OLYMPUS is primarily involved in supporting various training activities to spread awareness among Indian users through its strong marketing team and is committed to continue to participate in such events in future as well.
Olympus has been spending heavily and expanding its sales and service network through state of the art National Service Workshops at Head Office Gurgaon and 8 more locations – qualifying the most stringent protocols followed at Japan, covering the vast geography of India. Olympus has been growing rapidly in India and is committed to dedicate all required sales, service and marketing resources for further growth in such a vibrant emerging market.
ResMed is a global leader in the development, manufacturing and marketing of innovative medical products for the treatment and management of respiratory disorders with a focus on sleep-disordered breathing. ResMed is committed to advancing technology in sleep and respiratory medicine and commercializing innovative products incorporating these technologies on a ¬¬¬¬global basis. An excellent leadership and a team of 5000+ employees with diverse professional, technical, marketing, medical and manufacturing skills, we sell a comprehensive range of products in more than 100 countries worldwide through direct offices and a network of distributors.
Founded by Dr.Peter Farrell, current chairman of Board, in 1989 in Sydney, company now operates from their headquarters in San Diego US, Regional Europe headquarter in Paris and Asia Pacific headquarter in Sydney. ResMed has manufacturing facilities in Australia, Singapore, France and USA and has 3000+ patents/designs issued or pending to its credit. We are committed to creating the world’s best tech-driven medical device company – improving quality of life, reducing the impact of chronic disease and saving healthcare costs.
At ResMed we believe that every breath is an opportunity to make a positive change to people’s lives and we do this with award-winning medical devices and cutting-edge cloud-based software applications that diagnose, treat and manage sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. A true global leader in connected care, we have more than 2 million patients remotely monitored every day.